New Cancer Drug Gotistobart Shows Promise Against Aggressive Lung Cancer
Novel antibody therapy extends survival in patients with treatment-resistant squamous lung cancer compared to standard chemotherapy.
2017 articles in this topic
Novel antibody therapy extends survival in patients with treatment-resistant squamous lung cancer compared to standard chemotherapy.
New brain imaging shows ALS affects reward pathways linked to appetite loss, revealing the disease extends far beyond motor symptoms.
Large genomic study reveals distinct mutation patterns between younger and older breast cancer patients, pointing to personalized therapies.
Family-centered therapy significantly improved frailty, mental health, and quality of life in older gastric cancer patients.
Major analysis of 8,043 patients finds tirzepatide doesn't increase serious adverse events, though GI side effects are common.
Targeted brain stimulation helps stroke patients recover motor function by rewiring neural circuits in unexpected brain regions.
Researchers developed ERADECs, a breakthrough technology that hijacks cellular cleanup systems to eliminate hard-to-target proteins.
Nature explores the emerging science behind red-light therapy and its potential health applications.
Researchers develop novel eye drop delivery system using pig semen to transport cancer drugs directly to tumors in mice.
Deep learning reveals distinct aging phases for men and women, with molecular changes accelerating at specific life transitions.
Research from sub-Saharan Africa shows urbanization dramatically alters inflammaging patterns, challenging universal aging models.
Anti-malarial drug shows promise for preventing premature ovarian failure caused by cancer treatment in mouse studies.